Inaugural Almac McKervey Award Presented for Excellence in Chemistry
October 25, 2018
Craigavon, N.I., 25 October 2018 – Almac Group, the global contract pharmaceutical development and manufacturing organisation, is delighted to announce that the first ‘Almac McKervey Award’ for Excellence in Organic Chemistry has been awarded.
The award, a commemoration to the life and work of one of Ireland’s most distinguished scientists, Professor Tony McKervey, who passed away in June 2017, was made to Queen’s University Belfast Medicinal Chemistry student, Eilish Bonner.
Eilish, who is originally from Dungloe in County Donegal, was presented with the award by Dr Stephen Barr, Managing Director, Almac Sciences. She also received a £1,500 bursary towards her tuition fees and a 12 month placement with Almac to gain industry experience and mentorship.
Born in Ederney, Co Fermanagh in 1938, Tony earned a degree in Chemistry from Queen’s University Belfast in 1961. A former Professor of Organic Chemistry at both University College Cork and Queen’s University Belfast, Tony founded Almac’s Sciences Business Unit in 1992 and continued to support Almac as a member of the Sciences’ senior management team until his death at the age of 78.
Professor McKervey was an esteemed academic and an industry expert, having received the ASTRA Award of the Royal Dublin Society in 1986 and the Boyle-Higgins Gold Medal of the Institute of Chemistry of Ireland in 1993. He also authored over 270 published research papers in world-renowned journals.
Dr Barr said: “We chose to name an award after our esteemed colleague and friend, Tony, as a fitting tribute to someone whose leadership, exemplary work ethic and kind demeanour inspired many of us during his long service with Almac. Tony was committed to supporting students with a shared passion for science and this award is designed to support outstanding achievement in organic chemistry, something that our panel of experts felt strongly was exemplified in Eilish’s dedication to her studies.”
Eilish commented: “I am delighted and honoured to accept this prestigious award – particularly in its first year. I have enjoyed my degree at Queen’s thus far and am excited to be gaining hands on experience during my placement at Almac and working alongside so many chemistry experts. Professor McKervey was such an inspiration to students and I am humbled to receive an award in his name.”
“Queen’s is very proud of its long tradition of working with great companies, many like Almac, who employ outstanding QUB graduates from the sciences.” Commented Professor Mark Price, Pro-vice Chancellor for the Faculty of Engineering and Physical Sciences. “It is lovely to see an outstanding student like Eilish be recognised for her achievements through the generosity of this award, given in the honour of one of our most renowned graduates in the sciences. The stars of the past are helping to shine a light on the stars of the future!”
Following the ceremony, Professor McKervey’s daughter, Henrietta, unveiled a perpetual commemorative wall plaque at the David Keir building at Queen’s University – a replica of which has been erected in Almac’s global headquarter facility in Craigavon.
The Almac McKervey Award, which is open to students studying Chemistry or Medicinal Chemistry at the School of Chemistry and Chemical Engineering, Queen’s University Belfast, will be presented each year to the top applicant, selected on both their academic achievement and performance at an interview with Almac’s chemistry experts.
About Almac Group
A unique culture delivering exceptional solutions
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.
Our innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has grown organically over the past five decades now employing over 5,000 highly skilled personnel across 17 facilities including Europe, the US and Asia. Click here to view our facilities.
We have a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.